← Back to Search

Mindfulness Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Stephen P Becker, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test mindfulness meditation exercises called Mindful Awareness Practices (MAPs) for adolescents with ADHD and additional symptoms like daydreaming and mental fogginess. The goal is to see if these exercises can help them stay focused and reduce these extra symptoms. Mindfulness meditation has been proposed to improve attention, reduce stress, and improve mood in individuals with ADHD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mindfulness
Secondary study objectives
Attention Deficit Disorder
Syndrome
Change in mind wandering: Mind-Wandering Questionnaire (MWQ)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mindfulness TreatmentExperimental Treatment1 Intervention
This arm consists of the mindfulness treatment that will be administered to all participants in the single-arm open trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Awareness Practices (MAPs)
2017
N/A
~100

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
835 Previous Clinical Trials
6,565,151 Total Patients Enrolled
33 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
4,057 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Stephen P Becker, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
~5 spots leftby Nov 2025